The Current Ratio as of September 2024 (TTM) for Longeveron Inc. (LGVN) is 4.18

According to Longeveron Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.18. This represents a change of 112.14% compared to the average of 1.97 of the last 4 quarters.

Longeveron Inc. (LGVN) Historical Current Ratio (quarterly & annually)

How has LGVN Current Ratio performed in the past?

The mean historical Current Ratio of Longeveron Inc. over the last ten years is 3.71. The current 4.18 Current Ratio has changed 11.15% with respect to the historical average. Over the past ten years (40 quarters), LGVN's Current Ratio was at its highest in in the March 2022 quarter at 13.28. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Longeveron Inc. (LGVN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Longeveron Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Longeveron Inc. (LGVN) Average Current Ratio

How has LGVN Current Ratio performed in the past?

The current Current Ratio of Longeveron Inc. (LGVN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Longeveron Inc. (LGVN) Current Ratio vs. Peers

How is LGVN’s Current Ratio compared to its peers?

Longeveron Inc.’s Current Ratio is less than Nutriband Inc. (6.57), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than RenovoRx, Inc. (4.39), less than Virax Biolabs Group Limited (25.94), less than Generation Bio Co. (7.42), less than Kronos Bio, Inc. (8.49), less than Erasca, Inc. (16.79), less than C4 Therapeutics, Inc. (5.09), less than Edgewise Therapeutics, Inc. (30.24), less than Surrozen, Inc. (6.96), less than Bolt Biotherapeutics, Inc. (4.28), less than Larimar Therapeutics, Inc. (10.93), less than Keros Therapeutics, Inc. (20.37), less than Kezar Life Sciences, Inc. (9.58), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.10), greater than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (19.22), greater than ABVC BioPharma, Inc. (0.33), greater than Indaptus Therapeutics, Inc. (3.88), less than Pasithea Therapeutics Corp. (6.20), greater than Better Therapeutics, Inc. (0.57), greater than Forte Biosciences, Inc. (2.82),

Build a custom stock screener for Longeveron Inc. (LGVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longeveron Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Longeveron Inc. (LGVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Longeveron Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.